Chiasma Inc (CHMA) Stock News

NASDAQ:CHMA - Nasdaq -

3.76 -0.24 (-6%)

After market: 3.78 +0.02 (+0.53%)

CHMA Latest News, Press Relases and Analysis

All

Press Releases

4 years ago - Pulmatrix, Inc.

Pulmatrix appoints Director Anand Varadan

Mentions: PULM

4 years ago - Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers Cellect Biotechnology (NASDAQ:APOP

Mentions: PTE FOLD VEEV CLRB ...

4 years ago - Benzinga

Chiasma Files Mycapssa European Application For Acromegaly

Chiasma Inc (NASDAQ: CHMA) submitted a marketing application to the European Medicines Agency seeking approval of Mycapssa (oral octreotide capsules) as...

4 years ago - Monteverde & Associates PC

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Chiasma, Inc. - CHMA

4 years ago - Kahn Swick & Foti, LLC

CHIASMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chiasma, Inc. - CHMA